Mar 28, 2022 11:20 am EDT Abeona Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Mar 14, 2022 7:30 am EDT Abeona Therapeutics Achieves Target Enrollment in Pivotal Phase 3 VIITAL™ Study of EB-101 in RDEB
Dec 17, 2021 9:00 am EST Abeona Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
Nov 18, 2021 7:30 am EST Abeona Therapeutics Announces Support of EB Research Partnership's Venture Into Cures Event to Raise Awareness for Education and Research of Epidermolysis Bullosa
Nov 17, 2021 7:30 am EST Abeona Therapeutics Announces Presentation on Pivotal Transpher A Study of ABO-102 in MPS IIIA at the 14th ICIEM Conference
Nov 16, 2021 7:30 am EST Abeona Therapeutics Announces Participation at the Jefferies London Healthcare Conference
